Logo image of AGIL

AGILETHOUGHT INC (AGIL) Stock Fundamental Analysis

NASDAQ:AGIL - Nasdaq - US00857F1003 - Common Stock - Currency: USD

0.197  +0.11 (+137.35%)

After market: 0.143 -0.05 (-27.41%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AGIL. AGIL was compared to 82 industry peers in the IT Services industry. AGIL has a bad profitability rating. Also its financial health evaluation is rather negative. AGIL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AGIL has reported negative net income.
In the past year AGIL had a positive cash flow from operations.
AGIL had negative earnings in 4 of the past 5 years.
In multiple years AGIL reported negative operating cash flow during the last 5 years.
AGIL Yearly Net Income VS EBIT VS OCF VS FCFAGIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 10M -10M -20M

1.2 Ratios

AGIL has a worse Return On Assets (-36.78%) than 87.36% of its industry peers.
AGIL has a Return On Equity of -234.27%. This is in the lower half of the industry: AGIL underperforms 78.16% of its industry peers.
Industry RankSector Rank
ROA -36.78%
ROE -234.27%
ROIC N/A
ROA(3y)-10.12%
ROA(5y)N/A
ROE(3y)-63.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGIL Yearly ROA, ROE, ROICAGIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -50 -100

1.3 Margins

AGIL has a Gross Margin (33.04%) which is comparable to the rest of the industry.
AGIL's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AGIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
AGIL Yearly Profit, Operating, Gross MarginsAGIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

AGIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGIL has less shares outstanding
AGIL has a worse debt/assets ratio than last year.
AGIL Yearly Shares OutstandingAGIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
AGIL Yearly Total Debt VS Total AssetsAGIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

AGIL has an Altman-Z score of -1.22. This is a bad value and indicates that AGIL is not financially healthy and even has some risk of bankruptcy.
AGIL has a worse Altman-Z score (-1.22) than 85.06% of its industry peers.
AGIL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, AGIL belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC7.24%
AGIL Yearly LT Debt VS Equity VS FCFAGIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

AGIL has a Current Ratio of 0.31. This is a bad value and indicates that AGIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, AGIL is not doing good in the industry: 98.85% of the companies in the same industry are doing better.
AGIL has a Quick Ratio of 0.31. This is a bad value and indicates that AGIL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.31, AGIL is doing worse than 97.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
AGIL Yearly Current Assets VS Current LiabilitesAGIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for AGIL have decreased strongly by -119.70% in the last year.
AGIL shows a decrease in Revenue. In the last year, the revenue decreased by -3.63%.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-119.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y0.59%
Revenue growth 5YN/A
Sales Q2Q%-16.98%

3.2 Future

The Earnings Per Share is expected to grow by 19.72% on average over the next years. This is quite good.
Based on estimates for the next years, AGIL will show a small growth in Revenue. The Revenue will grow by 2.00% on average per year.
EPS Next Y-190.13%
EPS Next 2Y19.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.66%
Revenue Next 2Y2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGIL Yearly Revenue VS EstimatesAGIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AGIL Yearly EPS VS EstimatesAGIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

AGIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AGIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGIL Price Earnings VS Forward Price EarningsAGIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGIL Per share dataAGIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

AGIL's earnings are expected to grow with 19.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AGIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGILETHOUGHT INC

NASDAQ:AGIL (11/22/2023, 8:00:00 PM)

After market: 0.143 -0.05 (-27.41%)

0.197

+0.11 (+137.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)N/A N/A
Inst Owners0.4%
Inst Owner Change-53.59%
Ins Owners17.35%
Ins Owner Change0%
Market Cap10.32M
Analysts43.33
Price Target2.04 (935.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.86%
Min EPS beat(2)-380.2%
Max EPS beat(2)-357.52%
EPS beat(4)1
Avg EPS beat(4)-188.67%
Min EPS beat(4)-380.2%
Max EPS beat(4)160.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.87%
Min Revenue beat(2)-8.93%
Max Revenue beat(2)-4.82%
Revenue beat(4)1
Avg Revenue beat(4)-3.2%
Min Revenue beat(4)-8.93%
Max Revenue beat(4)1.04%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 8.75
P/B 0.35
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.02
OCFY11.43%
SpS3.18
BVpS0.56
TBVpS-1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.78%
ROE -234.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.04%
FCFM N/A
ROA(3y)-10.12%
ROA(5y)N/A
ROE(3y)-63.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.88%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -1.22
F-Score5
WACC7.24%
ROIC/WACCN/A
Cap/Depr(3y)16.84%
Cap/Depr(5y)20.07%
Cap/Sales(3y)0.71%
Cap/Sales(5y)0.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
EPS Next Y-190.13%
EPS Next 2Y19.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y0.59%
Revenue growth 5YN/A
Sales Q2Q%-16.98%
Revenue Next Year-6.66%
Revenue Next 2Y2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y95.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.7%
OCF growth 3YN/A
OCF growth 5YN/A